6 results match your criteria: "Chile Millennium Institute on Immunology and Immunotherapy[Affiliation]"
Medicine (Baltimore)
April 2018
Hematology and Oncology Department, Faculty of Medicine, Pontificia Universidad Católica de Chile (PUC) Department of Physiology, Faculty of Biological Sciences, PUC Biomedical Research Consortium of Chile Millennium Institute on Immunology and Immunotherapy, PUC Core Biodata, Advanced Center for Chronic Diseases, PUC Center UC Investigation in Oncology, PUC Department of Pathology, Faculty of Medicine, PUC The Institute for Biological and Medical Engineering, PUC Center of Clinical Research, Health Technology Assessment Unit, PUC Department of Public Health, PUC Center of Excellence in Precision Medicine, Macul Department of Gastrointestinal Surgery, PUC, Santiago, Chile Hospital Universitario Central de Asturias, Oviedo Hospital Morales Meseguer, Murcia, Spain Hospital Provincial de Neuquén, Neuquén, Argentina.
Unlabelled: Gastric cancer (GC) is the world's second-leading cause of neoplastic mortality. Genetic alterations, response to treatments, and mortality rates are highly heterogeneous across different regions. Within Latin America, GC is the leading cause of cancer death in Chile, affecting 17.
View Article and Find Full Text PDFDis Model Mech
April 2016
Laboratory of Biology and Molecular Physiopathology, Department of Biological Sciences, Faculty of Biological Sciences & Faculty of Medicine, Universidad Andrés Bello, Santiago 8370146, Chile Millennium Institute on Immunology and Immunotherapy, Santiago 8370146, Chile
Immobilization is a form of disuse characterized by a loss of strength and muscle mass. Among the main features are decreased IGF-1/Akt signalling and increased ubiquitin-proteasome pathway signalling, which induce greater myosin heavy chain degradation. Activation of the classical renin-angiotensin system (RAS) causes deleterious effects in skeletal muscle, including muscle wasting.
View Article and Find Full Text PDFInfect Immun
February 2016
Laboratorio de Fisiopatología Integrativa, Departamento de Ciencias Biologicas, Facultad de Ciencias Biologicas and Facultad de Medicina, Universidad Andres Bello, Santiago, Chile Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
Infect Immun
September 2014
Laboratorio de Fisiopatología Integrativa, Departamento de Ciencias Biologicas, Facultad de Ciencias Biologicas and Facultad de Medicina, Universidad Andres Bello, Santiago, Chile Millennium Institute on Immunology and Immunotherapy, Santiago, Chile
During endotoxemia-induced inflammatory disease, bacterial endotoxins circulate in the bloodstream and interact with endothelial cells (ECs), inducing dysfunction of the ECs. We previously reported that endotoxins induce the conversion of ECs into activated fibroblasts. Through endotoxin-induced endothelial fibrosis, ECs change their morphology and their protein expression pattern, thereby suppressing endothelial markers and upregulating fibrotic proteins.
View Article and Find Full Text PDFPLoS One
December 2014
Immunology Program, Faculty of Medicine, University of Chile Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.
Natural rubber latex (NRL; Hevea brasiliensis) allergy is an IgE-mediated reaction to latex proteins. When latex glove exposure is the main sensitizing agent, Hev b 5 is one of the major allergens. Dendritic cells (DC), the main antigen presenting cells, modulated with pharmacological agents can restore tolerance in several experimental models, including allergy.
View Article and Find Full Text PDFClin Exp Immunol
March 2013
Programa Disciplinario de Inmunología, Instituto de Ciencias Biomédicas, Universidad de Chile/Millennium Institute on Immunology and Immunotherapy-Chile, Santiago, Chile.
A new paradigm has emerged relating the pathogenesis of rheumatoid arthritis (RA), focused on the balance between T helper type 17 cells and regulatory T cells (T(regs) ). In humans, both subpopulations depend on transforming growth factor (TGF)-β for their induction, but in the presence of inflammatory cytokines, such as interleukin (IL)-6, the generation of Th17 is favoured. Tocilizumab is a therapeutic antibody targeting the IL-6 receptor (IL-6R), which has demonstrated encouraging results in RA.
View Article and Find Full Text PDF